F&P reports double-digit increase for home care
By HME News Staff
Updated 8:56 AM CST, Wed November 29, 2023
AUCKLAND, New Zealand – Fisher & Paykel Healthcare reported revenue of $314.4 million for its Homecare Product Group for the first half of its 2024 financial year, a 26% increase from the prior comparable period.
The company reported revenue for masks and accessories for obstructive sleep apnea increased 28% in constant currency.
“Evora Full has been available in the United States for more than a year, and it continues to see impressive demand and positive customer feedback,” said Lewis Gradon, managing director and CEO. “We are set to build on this momentum next year as our revolutionary new F&P Solo mask is rolled out beyond New Zealand and Australia.”
F&P reported total operating revenue of $803.7 million for the six months ended Sept. 30, a 16% increase from the prior comparable period. It reported net profit after tax of $107.3 million, a 12% increase.
The company reported revenue of $487.5 million for its Hospital Product Group, an 11% increase from the prior comparable period.
At current exchange rates, F&P expects total operating revenue of $1.7 billion and a net profit after tax of $250 million to $260 million for the full 2024 financial year.
Comments